SCHEMBL4435774

SCHEMBL4435774

C[Sn](C)(C)c1nn(Cc2ccccc2)c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 2/20 0.54
▸ CNR2 P34972 2/20 0.54
▸ ACHE P22303 1/20 0.54
▸ PDE5A O76074 4/20 0.51
▸ CYP1A2 P05177 4/20 0.49
▸ CYP2D6 P10635 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ GUCY1B2 O75343 1/20 0.49
▸ CHRM2 P08172 1/20 0.49
▸ HTR1A P08908 1/20 0.49
▸ ADRA2A P08913 1/20 0.49
▸ CHRM1 P11229 1/20 0.49
▸ DRD1 P21728 1/20 0.49
▸ SLC6A2 P23975 1/20 0.49
▸ SLC6A4 P31645 1/20 0.49
▸ GUCY1A2 P33402 1/20 0.49
▸ ADRA1A P35348 1/20 0.49
▸ OPRM1 P35372 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ SLC6A3 Q01959 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17508619 0.86 CNR2 (0.63) CNR1CNR2ACHEKDM4EALDH1A1
SCHEMBL7810924 0.79 LMNA (0.46) CYP1A2KDM4ECHRM1ALDH1A1CYP2C19
SCHEMBL13777341 0.78 L3MBTL1 (0.62) CNR1CNR2ACHEPDE5ACYP1A2
SCHEMBL29342349 0.76 CNR1 (0.59) CNR1CNR2ACHEPDE5ACYP1A2
SCHEMBL17696321 0.76 CNR1 (0.59) CNR1CNR2ACHEPDE5ACYP1A2
SCHEMBL8373357 0.75 SLC16A3 (0.58) CNR1CNR2ACHEPDE5ACYP1A2
SCHEMBL1226080 0.75 CNR1 (0.58) CNR1CNR2ACHEPDE5ACYP1A2
SCHEMBL9231345 0.75 CNR1 (0.58) CNR1CNR2ACHEPDE5ACYP1A2
SCHEMBL1898956 0.75 CNR1 (0.58) CNR1CNR2ACHEPDE5ACYP1A2
SCHEMBL958473 0.75 CNR1 (0.58) CNR1CNR2ACHEPDE5ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934311-B1 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER HEALTHCARE AG (DE) 2009-05-13 — — EP disclosed
WO-2007065010-A2 ANTI-ANGIOGENESIS COMPOUNDS HIF BIO, INC. (US) 2007-06-07 — — WO disclosed
EP-1686127-A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases Bayer HealthCare AG (DE) 2006-08-02 — — EP disclosed
US-6462068-B1 CARDIOVASCULAR DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2002-10-08 — — US disclosed
US-6414009-B1 CARDIOVASCULAR DISORDERS; ANTICOAGULANTS BAYER AKTIENGESELLSCHAFT (DE) 2002-07-02 — — US disclosed
US-6410740-B1 CYCLIZATION OF THE CORRESPONDING AMIDE BAYER AKTIENGESELLSCHAFT (DE) 2002-06-25 — — US disclosed
US-6387940-B1 CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2002-05-14 — — US disclosed
US-6166027-A Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases BAYER AKTIENGESELLSCHAFT (DE) 2000-12-26 — — US disclosed
CN-1241188-A Heterocyclylmethyl-substed pyrazol derivs. BAYER AG (DE) 2000-01-12 — — CN disclosed
EP-0934311-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES BAYER AG (DE) 1999-08-11 — — EP disclosed
WO-1998016507-A2 NEW HETEROCYCLYLMETHYL-SUBSTITUTED PYRAZOL DERIVATES AND THEIR USE FOR TREATING CARDIOVASCULAR DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1998-04-23 — — WO disclosed
Send feedback